Recombinant Human Myosin light chain 3 protein (GST tag N-Terminus)
Be the first to review this product! 리뷰 제출
|
(0 출판물)
Recombinant Human Myosin light chain 3 protein (GST tag N-Terminus) is a Human Full Length protein, in the 1 to 195 aa range, expressed in Wheat germ, suitable for ELISA, WB.
대체 명칭 보기
Myosin light chain 3, Cardiac myosin light chain 1, Ventricular myosin alkali light chain, Ventricular myosin light chain 1, Ventricular/slow twitch myosin alkali light chain, CMLC1, MLC1SB, VLCl, MLC-lV/sb, MYL3
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant Human Myosin light chain 3 protein (GST tag N-Terminus) (AB158937)
ab158937 on a 12.5% SDS-PAGE stained with Coomassie Blue.
Reactivity 정보
서열 정보
특성 및 보관 정보
제형
Purification 테크닉
배송 시 보관 조건
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MLC3 functions as an essential component of the myosin light chain complex. This complex regulates contractile activity in muscle cells by modulating the interaction between actin and myosin chains. MLC3 activates the mechanical movement of myosin chains impacting cardiac and skeletal muscle contraction. When activated it affects the speed and strength of muscle contraction and it also has a role in muscle differentiation and development.
Pathways
MLC3 is an integral part of the muscle contraction pathway. It interacts with proteins such as tropomyosin and troponin which are important for the regulation of muscle contraction. Additionally MLC3 participates in the calcium signaling pathway which is pivotal for contraction processes in muscles. This interaction helps to control the cytosolic calcium concentration a critical factor in muscle contraction dynamics.
일반 정보
기능
Regulatory light chain of myosin. Does not bind calcium.
Post-translational modifications
The N-terminus is blocked.. N-terminus is methylated by METTL11A/NTM1.
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com